WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 76.00
-0.50 (-0.65%)
Oct 9, 2025, 1:30 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.46 billion as of October 10, 2025. Its market cap has increased by 18.25% in one year.
Market Cap
3.46B
Enterprise Value
3.98B
Revenue
1.02B
Ranking
n/a
PE Ratio
18.72
Stock Price
76.00
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has increased from 3.43B to 3.46B, an increase of 0.76%. That is a compound annual growth rate of 0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 3.46B | 6.58% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |